ImageneBio Inc cash flow to debt ratio of -478.68% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

ImageneBio Inc's free cash flow has decreased 4.00% from $-46.00M last year to $-47.84M, signaling decreasing performance

ImageneBio Inc's debt to equity ratio is 0.01, which means that the company's assets are healthy financed, signaling financial stability.

ImageneBio Inc's debt has decreased relative to shareholder equity from 0.06 last year to 0.01 today, signaling strengthened financials

ImageneBio Inc has a net cash position, so leverage is healthy.

ImageneBio Inc earns at least as much interest as it pays. Interest obligations are fully covered.

ImageneBio Inc's profit margin has increased (-100.00%) in the last year from -1.04K% to 0.00%, signaling increasing performance

ImageneBio Inc's short-term assets of $140.29M exceed its short-term liabilities of $11.23M

ImageneBio Inc's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

ImageneBio Inc's return on equity of -38.99%, is lower than 15.00%, indicating bad performance

ImageneBio Inc's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

ImageneBio Inc had positive net income in only 0 out of 5 years, indicating unstable earnings

ImageneBio Inc has negative free cash flow, indicating the company is burning cash rather than generating it

ImageneBio Inc has negative free cash flow, indicating cash burn

ImageneBio Inc's yearly earnings has decreased 24.01% since last year from $-36.57M to $-45.35M, signaling decreasing performance

ImageneBio Inc's yearly revenue has increased 0.00% since last year from $0.00 to $0.00, signaling increasing performance

ROIC -39.76% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

ImageneBio Inc's 3-year revenue CAGR of -62.86% is negative, indicating declining revenue over the past 3 years

ImageneBio Inc had revenue growth in only 1 out of 5 years, indicating inconsistent revenue performance

ImageneBio Inc had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

ImageneBio Inc has insufficient data to evaluate this check.

ImageneBio Inc has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

ImageneBio Inc is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

ImageneBio Inc has negative or missing EBITDA, making EV/EBITDA ratio unreliable

ImageneBio Inc is overvalued relative to its fair value price of -9.08 based on Earnings Fair Value model

ImageneBio Inc has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

ImageneBio Inc has a price-to-book ratio of 0.65x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

ImageneBio Inc has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue